COLL
Price:
$37.19
Market Cap:
$1.20B
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-05-07
Stock Exchange
NASDAQ
Ticker
COLL
According to Collegium Pharmaceutical, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 13.98. This represents a change of 33.95% compared to the average of 10.44 of the last 4 quarters.
The mean historical PE Ratio of Collegium Pharmaceutical, Inc. over the last ten years is -10.41. The current 13.98 PE Ratio has changed -13526.16% with respect to the historical average. Over the past ten years (40 quarters), COLL's PE Ratio was at its highest in in the March 2020 quarter at 309.37. The PE Ratio was at its lowest in in the December 2019 quarter at -78.54.
Average
-10.41
Median
-6.29
Minimum
-84.50
Maximum
25.76
Discovering the peaks and valleys of Collegium Pharmaceutical, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 485.62%
Maximum Annual PE Ratio = 25.76
Minimum Annual Increase = -444.00%
Minimum Annual PE Ratio = -84.50
Year | PE Ratio | Change |
---|---|---|
2023 | 21.57 | -168.70% |
2022 | -31.39 | -444.00% |
2021 | 9.13 | -64.58% |
2020 | 25.76 | -130.49% |
2019 | -84.50 | 485.62% |
2018 | -14.43 | 93.34% |
2017 | -7.46 | 86.04% |
2016 | -4.01 | -70.64% |
2015 | -13.66 | 166.62% |
2014 | -5.12 | -9.60% |
The current PE Ratio of Collegium Pharmaceutical, Inc. (COLL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.23
5-year avg
-11.89
10-year avg
-10.41
Collegium Pharmaceutical, Inc.’s PE Ratio is less than Phibro Animal Health Corporation (324.20), less than ANI Pharmaceuticals, Inc. (43.28), greater than Procaps Group S.A. (4.69), less than Silver Spike Investment Corp. (14.29), greater than Amphastar Pharmaceuticals, Inc. (13.33), greater than Eagle Pharmaceuticals, Inc. (5.10), less than Alkermes plc (15.66), greater than Evolus, Inc. (-17.34), less than Prestige Consumer Healthcare Inc. (18.08), greater than Regencell Bioscience Holdings Limited (-18.48), greater than Pacira BioSciences, Inc. (10.06), greater than Intra-Cellular Therapies, Inc. (-90.48), less than Dr. Reddy's Laboratories Limited (19.95),
Company | PE Ratio | Market cap |
---|---|---|
324.20 | $788.20M | |
43.28 | $1.27B | |
4.69 | $218.91M | |
14.29 | $71.22M | |
13.33 | $2.21B | |
5.10 | $55.19M | |
15.66 | $4.42B | |
-17.34 | $928.12M | |
18.08 | $3.68B | |
-18.48 | $87.06M | |
10.06 | $638.86M | |
-90.48 | $7.77B | |
19.95 | $13.19B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Collegium Pharmaceutical, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Collegium Pharmaceutical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Collegium Pharmaceutical, Inc.'s PE Ratio?
How is the PE Ratio calculated for Collegium Pharmaceutical, Inc. (COLL)?
What is the highest PE Ratio for Collegium Pharmaceutical, Inc. (COLL)?
What is the 3-year average PE Ratio for Collegium Pharmaceutical, Inc. (COLL)?
What is the 5-year average PE Ratio for Collegium Pharmaceutical, Inc. (COLL)?
How does the current PE Ratio for Collegium Pharmaceutical, Inc. (COLL) compare to its historical average?